Tesamorelin, a lab-created compound , is attracting increasing interest for its potential advantages within the therapeutic field. This novel analogue of growth hormone releasing hormone functions by stimulating the secretion of HGH from the pituitary . While primarily investigated for the care of lipodystrophy – a disease characterized by uneven